Clinical Trial Update: Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Perampanel for reducing seizure frequency in patients with high-grade glioma and focal epilepsy has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intractable Epilepsy
• Malignant Glioma
• Seizure Disorder
• Who Glioma

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Mayo Clinic | Conditions: Intractable Epilepsy, Malignant Glioma | Phase 4 | Status: TERMINATED | Results posted: 2023-06-22